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Summary
Hedgehog (Hh) signals regulate invertebrate and vertebrate development, yet the role of the cascade in adipose develop-
ment was undefined. To analyze a potential function, we turned to Drosophila and mammalian models. Fat-body-specific
transgenic activation of Hh signaling inhibits fly fat formation. Conversely, fat-body-specific Hh blockade stimulated fly fat
formation. In mammalian models, sufficiency and necessity tests showed that Hh signaling also inhibits mammalian adipo-
genesis. Hh signals elicit this function early in adipogenesis, upstream of PPARg, potentially diverting preadipocytes as well
as multipotent mesenchymal prescursors away from adipogenesis and toward osteogenesis. Hh may elicit these effects by
inducing the expression of antiadipogenic transcription factors such as Gata2. These data support the notion that Hh sig-
naling plays a conserved role, from invertebrates to vertebrates, in inhibiting fat formation and highlighting the potential
of the Hh pathway as a therapeutic target for osteoporosis, lipodystrophy, diabetes, and obesity.Introduction
Fat-storing tissues play essential and conserved roles in inverte-
brates and vertebrates (McKay et al., 2003; Spiegelman and
Flier, 2001). Since the roles of fat are ancient, the regulatory cas-
cades that control fat storage may also be conserved. Although
much has been learned about the late stages of adipocyte differ-
entiation, relatively little is known about the conversion of unde-
termined mesodermal precursors into committed adipocytes
(Rosen and Spiegelman, 2000). These still-unidentified precur-
sors may generate adipocytes and other mesodermal deriva-
tives such as muscle, blood, and bone (Karsenty, 1998; Mikkola
and Orkin, 2002; Molkentin and Olson, 1996). The adipose line-
age is located throughout the body in stereotypic patterns and
anatomical positions in both invertebrates and vertebrates, sup-
porting the notion that developmental cues might be important
for proper formation and function of adipose tissues (Cinti,
2000; Hoshizaki et al., 1994). Such information is often derived
from developmental signaling pathways, such as Wnt, BMP,
and Hh, that have been conserved from invertebrates to verte-
brates (Cadigan and Nusse, 1997; Graff, 1997; Ingham and
McMahon, 2001). Since the roles and anatomical distributions
of fat are conserved, it is plausible that conserved developmen-
tal signaling pathways control aspects of fat biology.
The Hh pathway regulates the commitment of precursors into
a diverse array of cell fates (McMahon et al., 2003). Secreted Hh
proteins bind to a cell surface receptor complex consisting of
the negatively acting Patched (Ptc) receptors (Ptc1 and Ptc2)
and the seven-transmembrane receptor Smoothened (Smo).
The Hh signal is then conveyed from Smo to the nucleus, affect-
ing gene expression via the ci/Gli family of transcription factors.
Despite the importance of the Hh pathway, its role in adipogen-
esis is unclear. Extant data support both a proadipogenic and an
antiadipogenic role (Buhman et al., 2004; Martin et al., 2002;
Spinella-Jaegle et al., 2001; Sweet et al., 1996; van der HorstCELL METABOLISM 3, 25–34, JANUARY 2006 ª2006 ELSEVIER INC.et al., 2003; Wang et al., 2002; Wu et al., 2004). These results
were primarily derived in osteogenic conditions and from suffi-
ciency tests, notorious for producing spurious results. Since
the potential role of Hh on adipocyte formation has been in-
ferred primarily as a byproduct of its effect on osteogenesis,
key tests—including assessing necessity—in adipogenic lines,
such as 3T3-L1s, might be informative (MacDougald and Lane,
1995).
We found that components of the Hh pathway were ex-
pressed in theDrosophila melanogaster fat body, the fly adipose
tissue. Activating the Hh pathway decreased fly fat formation. In
contrast, fat-body-specific transgenic inhibition of Hh signaling
increased fat formation. Hh components are also expressed in
mammalian fat, and their levels respondeddynamically to adipo-
genesis and obesity. We found that Hh activation inhibited 3T3-
L1, NIH-3T3, and pluripotent mesenchymal cell adipogenesis,
while blocking the Hh pathway stimulated mammalian adipo-
genesis, mirroring the fly results. Hh acts early in the adipogenic
cascade, upstream of PPARg, possibly by altering the potential
fates that a precursor cell can adopt. In support of that, we found
that Hh signals induced the expression of osteogenic markers in
3T3-L1 adipogenic cells and in pluripotent mesenchymal cells.
Mechanistic studies suggest that the Hh signals repress adipo-
genesis by inducing antiadipogenic transcription factors such
as Gata2 and Gilz (Shi et al., 2003; Tong et al., 2000). In sum-
mary, the Hh pathway, in an evolutionarily conserved manner,
inhibits fat formation.
Results
Hh signals block D. melanogaster fat formation
The fat body is the adipose organ of Drosophila melanogaster
(Hoshizaki et al., 1994). To study fly fat, we initiated a broad two-
component enhancer trap screen (minimal promoter-Gal4,
UAS-GFP) selecting lines that expressed GFP in the fat bodyDOI 10.1016/j.cmet.2005.11.012 25
A R T I C L E(J.M.S. and J.M.G., unpublished data). One such line had the P
element inserted into the 50UTR of smo, the Hh receptor (data
not shown), supporting the idea that the Hh cascade may regu-
late fly fat biology. To further evaluate that notion, we explanted
the larval fat body, extracted RNA, and found that smo, ptc, and
ci (Hh transcription factor) were all expressed in developing fly
fat (Figure 1A). To investigate a potential cell autonomous func-
tion for Hh signals in fly fat formation, we specifically activated
the Hh pathway in the fly fat body with UAS/Gal4 transgenesis
(Brand et al., 1994). For this, we utilized a Dcg-Gal4 strain that
drives transgene expression in the fat body. To activate the
Hh pathway, we crossed the Dcg-Gal4 line with a UAS-ci-3P
strain containing an active ci (Wang et al., 2000). A potential
drawback of this approach is that the Dcg-Gal4 driver is ex-
pressed relatively late during fat body formation, after cell pro-
liferation ceases, potentially too late to observe effects on line-
age specification. Nonetheless, we utilized Dcg-Gal4 as it is
the best-characterized tool available (Hoshizaki et al., 1994).
To visualize the fat body, we ingressed a fat body-specific Dcg-
GFP reporter (J. Peters, J.M.S., and J.M.G., unpublished data).
Through a series of assays, we found that increasing Hh signal-
ing reduced the expression of the GFP fat body reporter, fly fat
accumulation, the size of the lipid droplets, and the expression
of fat body molecular markers, HLH106 (fly SREBP homolog),
and fly fatty acid synthase (Rosenfeld and Osborne, 1998) (Fig-
ures 1B–1D). We also increased fat body Hh signaling by gener-
ating transgenic flies that express UAS-hh and UAS-smo under
the control of the Dcg-Gal4 driver. Activating the Hh pathway
with either of these genes produced the same outcomes as ci
transgenesis establishing the generality of the effects of the Hh
pathway on fly fat formation (data not shown). To examine the
necessity of Hh signaling, we blocked the cascade with fat
body transgenesis of dominant-negative ci (DNCi) (Wang and
Jiang, 2004). In a series of assays, this produced the opposite
outcomes produced by hh, smo, and ci transgenesis. For exam-
ple, DNCi transgenesis increased the fluorescent intensity of
the GFP fat body reporter (data not shown). To quantify the
changes induced by activating or inhibiting the cascade, we an-
alyzed the triglyceride content of transgenic flies expressing
either the active ci or the DNCi and compared the results to
matched control flies. We found that active ci significantly de-
creased triglyceride accumulation while DNCi significantly in-
creased triglyceride content (Figure 1E). These data are consis-
tent with the notion that Hh signals function cell autonomously to
decrease fly fat formation, and the necessity results support an
endogenous role.
Hh cascade components are expressed
in mammalian fat
To see whether the inhibitory role might be conserved from in-
vertebrates to vertebrates, we evaluated Hh cascade compo-
nent expression in mouse fat. We found that many of the Hh
cascade components, including Smo, the negative regulatory
receptors Ptc1 and Ptc2, and the Gli family of Hh transcription
factors (ci homologs), were expressed in developing and adult
fat tissues based upon RT-PCR, real-time PCR, and in situ hy-
bridizations (data not shown). We also examined expression in
the widely studied adipogenic model murine 3T3-LI tissue cul-
ture cells (MacDougald and Lane, 1995). These fibroblast-like
cells, thought to resemble preadipocytes, when placed into ap-
propriate induction media, change into fat-storing cells that ex-26press many adipocyte markers. We induced 3T3-LI cells to form
adipocytes, extracted RNA during different stages of adipogen-
esis, and examined Hh pathway-component expression. As a
control, we analyzed the adipogenic transcription factor PPARg,
and as expected, its levels increased (Figure 2A). We also found
that during adipogenesis, the expression of positively acting Hh
components (Smo and the Glis) decreased, while expression of
the inhibitory receptors Ptc1 and Ptc2 increased (Figure 2A).
This dynamic pattern of expression is consistent with the idea
that Hh signals might block mammalian adipogenesis.
Hh signals inhibit mammalian adipogenesis
To test the potential role of theHh pathway inmammalian fat, we
induced 3T3-L1s to undergo adipogenesis in the presence of
vehicle or Sonic Hh protein (Shh) and assessed adipogenesis
Figure 1. The Hh pathway blocks D. melanogaster fat formation
A) The fat body was dissected from 200 D. melanogaster third instar larvae, and
the expression of the indicated components of the Hh pathway was assessed
by RT-PCR.
B–D) An activated form of ci, the Hh transcription factor, was specifically ex-
pressed in the fat body with the Gal4-UAS system, and fly fat formation was eval-
uated with a fat-body-specific GFP reporter ([B] red arrows indicate loss of dorsal
fat), Nile Red, a fat-specific stain (C), or molecular analysis of explanted fat bodies
(D). HLH106 (fly SREBP) and fas (fly fatty acid synthase) are fat body markers, and
rp49 serves as a loading control.
E) Triglyceride quantitation shows that active ci inhibits fly fat formation and that
dominant-negative ci (DNCi) increases fly fat formation. *p < 0.05CELL METABOLISM : JANUARY 2006
Hedgehog signaling inhibits fat formationFigure 2. TheHh cascade inhibits 3T3-L1 adipogen-
esis
A) 3T3-L1 cells were incubated in adipogenic induc-
tion media, RNA extracted on days 0, 4, and 8, and
semiquantitative RT-PCR was done for the indicated
transcripts. Expression levels of the positively acting
Hh pathway components (Smo, Glis) decrease dur-
ing adipogenesis, while the levels of the negatively
acting components (Ptc1, Ptc2) increase. HPRT
serves as a loading control.
B and C) 3T3-L1s were incubated in adipogenic in-
duction media in the presence of vehicle (2Shh) or
Shh protein, and fat formation was assessed based
upon morphology (B), Oil Red O staining (B), and tri-
glyceride quantitation (C). *p<0.01.
D) 3T3-L1s were infected with a retrovirus express-
ing either GFP or SmoA1, an activated form of the
Hh receptor Smo. Smo A1 reduced fat formation as
scored either morphologically (top) or by Oil Red O
staining (bottom).
E and F) RNA was extracted from induced 3T3-L1s
treated with vehicle or Shh (E) or infected with GFP
or SmoA1 expressing virus (F) and semiquantitative
RT-PCR was done for the indicated transcripts.
C/EBPa and PPARg are adipogenic transcription
factors; adipsin and aP2 mark differentiated adipo-
cytes. Pref-1 is a preadipocyte marker. HPRT serves
as a loading control. Gli1 is a positive control for Hh
pathway activation.microscopically, with Oil Red O staining, and with triglyceride
quantitation. We found that Hh blocked the morphological
changes associatedwith adipogenesis, that is, the cells retained
the appearance of uninduced 3T3-L1s, and this was reflected by
a marked reduction in Oil Red O staining and triglyceride accu-
mulation (Figures 2B and 2C).We also increased Hh signaling by
infecting 3T3-L1s with a control GFP virus or one containing
SmoA1, an activated form of the Hh receptor Smo (Taipale
et al., 2000). Microscopy and Oil Red O stains showed that
SmoA1 also reduced adipogenesis (Figure 2D). Next, we evalu-
ated levels of the adipogenic transcription factors C/EBPa and
PPARg, two genes, aP2 and adipsin, that are thought to mark
the terminally differentiated state, and Pref-1, whose expression
inversely correlates with adipogenesis (Rosen and Spiegelman,
2000; Sul et al., 2000). As a positive control for Hh activation, we
examined expression of Gli1, which, in addition to being a Hh
component, is a transcriptional target of the Hh signal (Marigo
et al., 1996). As expected, Shh increased Gli1 expression (Fig-
ure 2E). The molecular analyses also showed that Hh signalingCELL METABOLISM : JANUARY 2006blocked the adipogenic program as evidenced by reduced ex-
pression of C/EBPa, PPARg, aP2, and adipsin and increased
Pref-1 expression (Figure 2E). Similar results were obtained
with SmoA1 (Figure 2F). We also found that Shh and SmoA1 in-
hibited NIH-3T3 adipogenesis (data not shown).
Inhibiting Hh signaling increases mammalian
adipogenesis
To complement the sufficiency results, we undertook necessity
tests, blocking Hh signals in 3T3-L1s. For this, we expressed
either GFP or Gli2-DC4 (DNGli), a dominant-negative form of the
Hh transcription factor Gli2 (Sasaki et al., 1999). We found that
reducing Hh signaling increased adipogenesis based upon light
microscopy, Oil RedO staining, andmolecular analyses (Figures
3A and 3B). Pharmacological inhibitors provide a distinct and
alternative approach to blocking Hh signaling and provide ther-
apeutic potential. KAAD-cyclopamine (KAAD) is a specific and
selective inhibitor of Smo, the positively acting Hh receptor
(Chen et al., 2002). To block the Hh pathway, we added either27
A R T I C L Evehicle or KAAD to 3T3-L1 cells during adipogenic induction
and found that KAAD, like DNGli, increased adipogenesis
(Figure 3C).
Hh inhibits fat formation early in adipogenesis
To begin to understand how Hh signals alter adipogenesis, we
attempted to define the Shh-sensitive window by adding vehicle
or Shh to 3T3-L1s at 2-day intervals during induction. We
observed maximal inhibition of adipogenesis when Shh was
added during the first 3 days of induction, although a slight effect
Figure 3. Inhibiting the Hh pathway stimulates 3T3-L1 adipogenesis
A and B) 3T3-L1s were infected with a retrovirus expressing either GFP or DNGli,
a dominant-negative form of Gli2, a Hh transcription factor. DNGli increased fat
formation as assessed morphologically (A) by Oil Red O staining (A) or by molec-
ular analyses (B).
C) 3T3-L1s were incubated in adipogenic induction media in the presence of ve-
hicle (-KAAD) or KAAD-cyclopamine, a Hh inhibitor. Fat formation was analyzed
morphologically (top) and with Nile Red staining (bottom).28was observed when Shh treatment began on day 4 (Figures 4A
and 4B). Relatively little is understood about the mechanisms
that regulate the early stages of adipogenesis during which
the Hh pathway acts (MacDougald and Lane, 1995). However,
it is known that this is when mitotic clonal expansion occurs
(Tang et al., 2003). Since Hh can sometimes act as a proliferative
signal, it was possible that Hh signals inhibit adipogenesis by
stimulating proliferation. To test this, we added vehicle or Shh
to 3T3-L1s and counted cells each successive day as an esti-
mate of proliferation; however, cell number was not significantly
affected (Figure 4C). The small and statistically insignificant
change observed in the latter time points was not detected in
all experiments. We also assessed proliferation with a quantita-
tiveBrdUassay (Gratzner, 1982). Again, therewasno statistically
significant difference in cell proliferation and BrdU incorporation
between control and Shh-treated samples on any day examined
based uponeither inspection or quantitation ofmultiple indepen-
dent fields in multiple experiments (Figures 4D and 4E). As a fur-
ther test of cell cycle control, we evaluated Rb expression and
activity and found that neither was altered by Shh (see Figure 6A
below). These data support the notion that Hh signals do not in-
hibit adipogenesis by altering proliferation. This lack of effect on
cell culture is in accord with the fly data; the Hh effects observed
in flies were elicited independently of cellular proliferation as we
activated the Hh pathway in postmitotic fat-body cells.
Hh signaling induces the expression of bone markers
in 3T3-L1 cells
Since Hh signals inhibit 3T3-L1 adipogenesis during early time
points, it is possible that the Hh pathway blocks progression
from preadipocytes to fully differentiated fat, an idea supported
by the Hh-dependent increase in Pref-1 expression (Figure 2E).
Alternatively, theShh signalsmaydivert 3T3-L1 cells fromadipo-
genesis and toward alternative fates. This latter possibility
seemed less likely since 3T3-L1s are thought to be preadipo-
cytes already committed toward the adipogenic lineage (Mac-
Dougald and Lane, 1995). However, the Hh pathway controls
the specification of many mesodermal fates, for example pro-
moting hematopoeisis, myogenesis, and osteogenesis (Gering
and Patient, 2005; Li et al., 2004; Wu et al., 2004). To see
whether Hh could induce 3T3-L1s toward any of these fates,
we incubated 3T3-L1s in vehicle or Shh and analyzed expres-
sion of a panel of blood, muscle and bone markers. While we
did not observe any changes in the levels of the blood or muscle
markers (data not shown), we did find that Shh increased the ex-
pression levels of all four bone markers tested—two osteogenic
transcription factors, Runx2 and Osx, and two markers of oste-
ogenic differentiation, the parathyroid hormone receptor (PTHR)
and alkaline phosphatase (ALP) (Figure 5A).
Hh inhibits adipogenesis and stimulates osteogenesis
in multipotent mesenchymal cells
The data described above are consistent with the idea that Hh
signals may regulate the potency of mesenchymal stem cells,
promoting osteogenesis and inhibiting adipogenesis. To further
explore this notion, we examined the effects of Hh on C3H10T1/
2 (10T1/2) cells, a multipotent mesenchymal progenitor cell line
that can be induced to form a wide variety of fates including
muscle, cartilage, bone, and fat and as such has been proposed
to be a mesenchymal stem cell model (Taylor and Jones, 1979).
To determine whether Hh retained its antiadipogenic actions onCELL METABOLISM : JANUARY 2006
Hedgehog signaling inhibits fat formationFigure 4. The Hh pathway acts early during 3T3-L1 adipogenesis, independently
of the cell cycle
A andB) 3T3-L1s were incubated in adipogenic inductionmedia in the presence of
vehicle (2Shh) or Shh and fat formation was scored with Oil Red O staining (A) and
triglyceride quantitation (B).
C–E) 3T3-L1s were incubated in adipogenic induction media in the presence of
vehicle (2Shh) or Shh protein, and cellular proliferation was evaluated with cell
counts (C) or with a quantitative BrdU assay (D and E). No statistically significant
changes were detected at any time point in either assay. BrDu positive cells are
pink; DAPI staining in blue (D). Error bars represent SEM.CELL METABOLISM : JANUARY 200610T1/2s, we cultured the cells in adipogenic conditions with ve-
hicle or Shh. Microscopy and molecular analyses showed that
Hh blocked 10T1/2 adipogenesis (Figures 5B and 5C). To exam-
ine necessity, we cultured 10T1/2s in the Hh inhibitor KAAD or
vehicle. We found that KAAD stimulated 10T1/2 adipogenesis
(Figure 5D). To determine if Hhmight be pro-osteogenic tomulti-
potent mesenchymal progenitors, we treated 10T1/2s with ei-
ther vehicle or Shh and analyzed osteogenic marker expression.
Just as in 3T3-L1s, Hh induced 10T1/2 osteogenesis, increasing
expression of osteogenic transcription factors and markers of
terminal differentiation (Figure 5E).
Hh signals function upstream of PPARg
PPARg, a master regulator of the adipocyte lineage, begins to
be expressed in the time frame in which the Hh pathway acts
(Figures 4A and 4B) (Rosen and Spiegelman, 2000) and Hh sig-
nals alter PPARg expression (Figures 2 and 3), raising the possi-
bility that Hh acts upstream of PPARg. To further assess the ep-
istatic relationship between the two, we infected 3T3-L1 cells
with a GFP virus or a virus-containing PPARg. Then, we treated
the infected cells with Shh and evaluated adipogenesis.We found
that PPARg overcame the Shh-induced adipogenic blockade
(Figure 5F). We also observed a PPARg-dependent rescue of
the SmoA1-induced inhibition of adipogenesis in NIH-3T3s (Fig-
ure 5F). These data support the notion that during adipogenesis,
Hh signals function upstream of PPARg.
Hh signals require Gata to block adipogenesis
To further examine the mechanisms whereby the Hh pathway
might regulate PPARg expression and hence adipogenesis,
we analyzed the relevant literature and identified four genes
Rb, Gata2, Gata3, and Gilz that conformed to two criteria: (1)
they are reported to regulate either PPARg expression or adipo-
genesis, and (2) they can be regulated by Hh signals.
Rb, via cell cycle-dependent and -independent means, regu-
lates adipogenesis, and Hh signals can lead to the phosphoryla-
tion and inactivation of Rb (Chen et al., 1996; Duman-Scheel
et al., 2002; Fajas et al., 2002; Hansen et al., 2004; Kenney
and Rowitch, 2000). To test whether Hh inhibits adipogenesis
by regulating the expression or phosphorylation (i.e., activity)
levels of Rb, we incubated 3T3-L1s with vehicle or Shh, har-
vested cells at time zero, and every 4 hr until 28 hr, and assessed
Rb content and phosphorylation status by Western blotting in
which the phosphorylated, inactive form of Rb migrates slower.
By this test, it appeared that the Hh pathway did not alter the ex-
pression levels or activity of Rb (Figure 6A).
The Hh pathway controls specific neural fates by increasing
the expression of Gata2 (Craven et al., 2004). Gata2 and
Gata3 block adipogenesis by binding to and inhibiting the
PPARgpromoter/enhancer (Tong et al., 2000). Gilz is a transcrip-
tion factor that inhibits adipogenesis and microarray data indi-
cate that Hh can induce Gilz in mesenchymal stem cells (Ingram
et al., 2002; Shi et al., 2003). So it was plausible that Hh signaling
inhibits fat formation by increasing the expression of the anti-
adipogenic transcription factors Gata2, Gata3 and/or Gilz. To
test this, we incubated 3T3-L1s with vehicle or Shh and evalu-
ated Gata2, Gata3, and Gilz levels. After adipogenic induction,
Shh increased expression of all three (Figure 6B). Next, we
examined whether Shh could regulate their expression during
early adipogenesis, the relevant time frame (Figure 4). Based
upon real-time PCR analyses, it appeared that Shh significantly29
A R T I C L EFigure 5. Hh signaling is antiadipogenic and pro-osteogenic in 3T3-L1s and 10T1/2 pluripotent mesenchymal cells and functions upstream of PPARg
A) Hh signals induce the expression of bone markers in 3T3-L1s. 3T3-L1s were induced to form adipocytes in the presence of vehicle (2Shh) or Shh, and the levels of the
indicated osteogenic markers were assessed with semiquantitative RT-PCR. HPRT serves as a loading control.
B and C) 10T1/2 multipotent mesenchymal cells were incubated in adipogenic induction media in the presence of vehicle (2Shh) or Shh, which inhibited adipogenesis as
scored morphologically (B) or with real-time PCR analysis (C).
D) 10T1/2s were incubated in vehicle (2KAAD) or KAAD (Hh antagonist) and morphology showed that KAAD stimulated adipogenesis.
E) 10T1/2s were incubated in adipogenic induction media with vehicle or Shh, and osteogenic markers were assessed with real-time PCR. b-actin serves as a loading
control for real-time PCR (C and E).
F) 3T3-L1s were infected with a virus encoding either GFP or PPARg, and Shh protein was added throughout induction. PPARg reversed the Shh-dependent inhibition of
adipogenesis (top). NIH-3T3 cells expressing SmoA1, an activated form of the Hh receptor Smo, were infected with a virus encoding either GFP or PPARg and PPARg
rescued the SmoA1 blockade of adipogenesis (bottom). *p < 0.01altered Gata2 expression at both 12 and 24 hr (data not shown).
We also detected a moderate increase in Gata3 expression at
12, but not 24, hr, and no change in Gilz levels at 12 or 24 hr
(data not shown).
These data suggest that Shh might elicit its antiadipogenic ef-
fects by regulating Gata expression. If so, forced expression of
Gata should block the effects of KAAD, a Hh inhibitor. To test
this, we infected 3T3-L1 cells with a GFP or Gata2 virus and
then placed the cells into adipogenic inductionmedia containing
vehicle or KAAD. In this assay, Gata2 inhibited the ability of
KAAD to stimulate adipogenesis (Figures 6C and 6D). We also
evaluated whether inhibiting Gata2/3 could prevent the Shh-
dependent adipogenic blockade by infecting 3T3-L1s with GFP
or a dominant-negative Gata3 (DNGata) that blocks Gata2 and
Gata3 (Smith et al., 1995). We induced the GFP or DNGata cells
to become adipocytes in the presence of vehicle or Shh and
found that inhibiting Gata2/3 overcame the Shh adipogenic
block (Figures 6E and 6F). Therefore, Shh appears to function
upstream of Gata factors to elicit its antiadipogenic actions.
We also assessed Gata function in 10T1/2 cell fate specifica-
tion by infecting 10T1/2swith aGFPorGata virus. As in 3T3-L1s,30Gata blocked 10T1/2 adipogenesis (Figures 6G and 6H) and
reversed KAAD-stimulated adipogenesis (data not shown), sup-
porting the idea that Gata functions downstream of Hh for anti-
adipogenesis. Since Gata factors are required for the antiadipo-
genic functions of Hh, it seemed plausible that Gatas might also
have Shh’s pro-osteogenic actions. To test this, we examined
10T1/2s expressing GFP or Gata for levels of osteogenic
markers. Molecular analysis showed that Gata stimulated
10T1/2 osteogenesis as evidenced by the increased expression
of the osteogenic transcription factors Runx2 and Osx (Fig-
ure 6I).
Hh signals are altered in mouse models of obesity
The fly and cell culture data support the idea that the Hh path-
way might be relevant to mammalian fat biology. Since changes
in expression levels induced by physiological or pathophysio-
logical cues often indicate functional importance, we examined
potential changes in adipose tissue expression of the Hh signal-
ing components produced by either genetic or diet-induced
obesity (DIO). For DIO, we randomized 5-week old C57BL/6J
littermates to four months of either normal or high fat chow,CELL METABOLISM : JANUARY 2006
Hedgehog signaling inhibits fat formationextracted RNA from fat depots, and examined expression with
real-time PCR. We found that DIO significantly decreased ex-
pression levels of Smo, Gli1, Gli2, and Gli3 (Figure 7A), the
four positively acting cell autonomous components of the Hh
cascade. We also examined expression in fat tissues from 6-
month old Ob/Ob genetically obese mice compared to matched
controls and again detected an obesity-dependent decrease in
Smo, Gli1, Gli2, andGli3 expression (Figure 7B). The concordant
expression patterns in two obesity models support the idea that
Hh signals may be germane to fat pathophysiology.
Discussion
Adipose tissues play crucial roles in many biological processes
and the ability to store fat is found over a wide evolutionary dis-
tance. Homologous molecules control aspects of worm and
mammalian fat formation, so mechanisms underlying fat biol-
ogy, such as those that might be important in human diseases,
may well be conserved (Ashrafi et al., 2003; McKay et al., 2003).
Signaling pathways, such as BMP, Wnt and Hh, are conserved,
not only in terms of the components that constitute the path-
ways, but also in their biological roles (Cadigan and Nusse,
1997; Graff, 1997; Ingham and McMahon, 2001). Wnt and
BMP signals regulate mammalian adipogenesis, however the
role of the Hh pathway was undefined (Ross et al., 2000; Sottile
and Seuwen, 2000). Since a variety of small molecule activators
and inhibitors of the Hh cascade have been developed and be-
cause diseases of fat tissues, such as lipodystrophy, obesity,
and diabetes, are major causes of morbidity andmortality, iden-
tifying a potential role for the Hh pathway in adipose biology
could have therapeutic implications.
In this study, we provide evidence that the Hh pathway might
play a conserved role in fat biology. We found that Hh pathway
components were expressed in the fly fat body. Hh pathway
components were also expressed in developing and adult
mouse fat and their levels were regulated by adipogenesis and
obesity. The function of the Hh pathway also appeared to be
conserved as sufficiency and necessity tests support the notion
that the Hh pathway blocks fly and mammalian fat formation.
Mechanistic studies showed that Hh signals blocked the early
steps of adipogenesis, presumably after mitotic clonal expan-
sion. Consistent with that temporal placement, epistasis studies
support the idea that Hh acts upstream of PPARg. We also
found that Hh signals increased the expression levels of three
antiadipogenic genes: Gata2, Gata3, and Gilz (Ingram et al.,
2002; Shi et al., 2003; Tong et al., 2000). This expression ap-
peared to be functionally significant as Hh signals required
Gata to elicit antiadipogenic actions. So it is possible that Hh
signals inhibit adipogenesis at least in part by regulating Gata
expression.
Based upon the timing and epistasis results, it seemed plau-
sible that Hh signals keep 3T3-L1s as preadipocytes or divert
the cells to alternative fates. Molecular analyses support both
notions; we observed an increase in the expression of Pref-1,
a preadipocyte marker, and also of bone markers. We also
found that Hh was antiadipogenic and pro-osteogenic in
C3H10T1/2 pluripotent mesenchymal cells. Gata appeared to
have similar functions to Hh, but this does not exclude the pos-
sibility that other mechanisms downstream of Hh exist. It ap-
pears that the Hh cascade induces an antiadipogenic program
leading to down-regulation of the key adipogenic transcriptionCELL METABOLISM : JANUARY 2006factor PPARg as well as a pro-osteogenic program inducing ex-
pression of osteogenic transcription factors such as Runx2. So
Hh may act upon an unidentified population of mesenchymal
stem cells to promote osteogenesis at the expense of adipogen-
esis. If so, the increase in fat and decrease in bone mass ob-
served with aging might be accounted for by a reduction in
Hh signals or may be reversed or prevented by activating the
cascade.
Taken together, the results support the notion that the Hh
pathway inhibits fat formation in a conservedmanner from inver-
tebrates to mammalian cellular models. Signaling pathways and
receptors, especially seven transmembrane receptors such as
Smo, are often amenable to therapeutics as demonstrated by
the identification of small molecules that modulate the Hh path-
way (Bak et al., 2003; Chen et al., 2002; Taipale et al., 2000). So
our data support the notion that the Hh pathway might be an
appropriate target for drugs to treat lipodystrophy, obesity, and
diabetes.
Experimental procedures
Retrovirus production and infection
Recombinant retroviruses (pMX, gift of Gary Nolan, and pLNCX2, Clontech)
were generated by calcium phosphate transfection of the retroviral con-
structs into Phoenix packaging cells. Media was changed the day after trans-
fection and viral supernatant was harvested at 48 and 72 hr post-transfec-
tion. Viral supernatant was passed through a 0.2 uM filter, polybrene
added to a final concentration of 6 mg/ml, and applied on successive days
to preconfluent 3T3-L1, NIH3T3 and C3H10T1/2 cells.
Cell culture and adipocyte differentiation
Mouse NIH-3T3 fibroblasts, C3H10T1/2 pluripotent mesenchymal cells, and
3T3-L1 preadipocytes were purchased from the American Type Culture Col-
lection and maintained in growth media (DMEM with 10% calf serum,
10 units/ml penicillin, 10 mg/ml streptomycin) at 37ºC in 5% CO2. Cells
were passaged before confluence and discarded after 10 passages. Media
changeswere performed every other day during cell maintenance and adipo-
genesis. 3T3-L1 cells were induced to form adipocytes as described (Mac-
Dougald and Lane, 1995; McKay et al., 2003). Briefly, postconfluent 3T3-
L1 cells were induced to form adipocytes by placing cells in induction media
(growth media supplemented with 1 mg/ml insulin) and further maintained in
induction media until analysis. For C3H10T1/2 and NIH-3T3 adipogenesis,
postconfluent cells were placed in growth media containing 250 nM dexa-
methasone, 0.5 mM isobutyl-methyl-xanthine and 1 mg/ml insulin for 2
(C3H10T1/2) or 4 (NIH-3T3) days and then maintained in growth media sup-
plemented with 1 mg/ml insulin until analysis. Recombinant Shh (R&D sys-
tems) dissolved in 2% BSA or an equal volume of 2% BSA was added to
the cells at the indicated times. Shh was added to cells at a final concentra-
tion of 300 ng/ml. KAAD-cyclopamine (Toronto Research Chemicals Inc.)
dissolved in DMSO or an equal volume of DMSO was added to the cells at
the indicated times. KAAD-cyclopamine was added to cells at a final concen-
tration of 3.6 mM.
Analysis of lipid accumulation
Lipid droplets in differentiated adipocytes were stained with Oil Red O and
extracted stain was quantified as described previously (McKay et al., 2003;
Ramirez-Zacarias et al., 1992). Briefly, monolayer cells were washed with
PBS, fixed in buffered formalin, incubated in freshly prepared Oil Red O so-
lution (four parts water mixedwith six parts 0.5%Oil RedO in isopropanol) for
30min, and washed several times with water to remove excess stain. Oil Red
O was extracted from stained cells with isopropanol and absorbance
(600nm) was measured to quantify stain. To quantify triglyceride levels, flies
or cells were lysed in 0.5% SDS/PBS and triglyceride content was measured
using the Infinity Triglyceride Reagent (Sigma) following manufacturer’s in-
structions. Protein concentrations used to normalize triglyceride content
were measured with a BCA protein assay kit (Pierce).31
A R T I C L EFigure 6. The Hh cascade requires Gata factors to inhibit fat formation
A) 3T3-L1s were incubated in adipogenic inductionmedia in the presence of vehicle (2) or Shh (+). Cell lysates were harvested at the indicated hours after Shh addition and
subjected to SDS-PAGE and Western blotting with anti-Rb antibodies. The phosphorylated and inactive Rb protein migrates slower than nonphosphorylated Rb, and the
levels of both forms are unaffected by Shh.
B) 3T3-L1 cells were induced to form adipocytes in the presence of vehicle or Shh, and the levels of the indicated antiadipogenic transcription factors were assessed with
semiquantitative RT-PCR. HPRT serves as a loading control.
C and D) 3T3-L1s infected with a retrovirus expressing either GFP or Gata2 were incubated in adipogenic induction media containing either vehicle (2KAAD) or KAAD (Hh
antagonist). Based upon Oil Red O staining (C) and triglyceride quantitation (D), Gata2 inhibits adipogenesis even when the Shh pathway was blocked.
E and F) 3T3-L1 cells were infected with a GFP or a dominant-negative Gata (DNGata) virus, incubated in adipogenic induction media containing either vehicle or
Shh, and adipogenesis was assessed by Oil Red O staining (E) or triglyceride quantitation (F); both show that Gata inhibition reverses the Shh-dependent adipogenic
blockade.32 CELL METABOLISM : JANUARY 2006
Hedgehog signaling inhibits fat formationRNA extraction and RT-PCR
Total RNA from flies, mouse perigonadal fat pads or cultured cells was ex-
tracted with Trizol (Invitrogen), DNase I-treated, and reverse-transcribed us-
ing random hexamers and M-MLV-reverse transcriptase (Invitrogen) to ob-
tain cDNA. Gene expression was analyzed using either semiquantitative
RT-PCR (McKay et al., 2003) or real-time PCR using SYBR Green Master
Mix reagent (Applied Biosystems, 7500 Real-Time PCR System). For the
semiquantitative assays, two concentrations of cDNA template were used
to demonstrate that the reaction conditions were semiquantitative. Real-
time PCR values for gene expression were normalized over b-actin expres-
sion. Primer sequences are available upon request.
BrdU proliferation assay
Cells were incubated in growth media containing BrdU (10 mg/ml) for two
hours on the indicated day of differentiation. Then the cells were rinsed in
PBS and fixed in 4% paraformaldehyde. Immunocytochemistry using anti-
BrdU was performed to identify labeled cells and DAPI staining identified nu-
clei. BrdU positive cells were counted from 10 random fields and averaged
for analysis.
Cell lysate preparation and Western blot
Monolayer cells were washed twice with ice-cold PBS, scraped into 0.2 ml of
lysis buffer (50 mM HEPES [pH 7.5], 150 mM NaCl, 10% glycerol, 100 mM
NaF, 0.2 mM Na-orthovanadate, 0.5% NP-40, 1.5 mM MgCl2, 1 mM EGTA,
1mMdithiothreitol, 1 mg/ml leupeptin, 10mMbenzamidine, 1 mg/ml pepstatin
A, 10.5 mg/ml aprotinin, and 1 mM phenylmethylsulfonyl fluoride), and incu-
bated for 20min on icewith intermittent vortexing. After a brief centrifugation,
the supernatant was mixed with Laemmli sample buffer and resolved by
SDS-polyacrylamide (10%) gel electrophoresis. Resolved proteins were blot-
ted onto a PVDF membrane (Immobilon-P, Millipore) and proteins were de-
tectedwith ECL (AmershamCorp.). Rb antibodieswere fromBDbiosciences.
Fly experiments
The Gal4/UAS system (Brand et al., 1994) was utilized for tissue-specific ac-
tivation or inhibition of the Hh pathway. 3rd instar larval fat bodies were dis-
Figure 7. Murine obesity regulates the Hh pathway
A)Matched littermates were fed 4 months with normal or high-fat chow (DIO), and
adipose depot gene expression was analyzed with real-time PCR, which demon-
strated a statistically significant decrease in Smo, Gli1, Gli2, and Gli3 expression in
DIO fat. n = 4.
B) Smo and Gli1, Gli2, and Gli3 levels are reduced in genetically obese (Ob/Ob) fat
depots compared to controls. n = 4. b-actin serves as a loading control for real-
time PCR. *p < 0.05CELL METABOLISM : JANUARY 2006sected in PBS under a microscope and lipid content of fat bodies was ana-
lyzed by Nile Red staining as described (McKay et al., 2003) and triglyceride
assays as described above. Fat body gene expression levels were analyzed
by semiquantitative RT-PCR as described above. Primer sequences are
available upon request.
Mouse studies
Pure inbred C57BL/6J mice and pure inbred C57BL/6J Ob/Ob mice were
purchased from the Jackson labs. Mice were housed in a 12:12 light:dark cy-
cle and chow and water were provided ad libitum. For diet-induced obesity
we mated the inbred C57BL/6J mice and then randomized 5-week old
C57BL/6J littermates to four months of either normal (4% fat, Teklad) or
high fat chow (60% fat, Research Diets). After four months on the appropriate
diet, RNA was extracted from identical fat depots from all mice in the cohorts
and molecular analyses were done as described above. Ob/Ob genetically
obese mice and matched controls were fed normal chow and at six months
of age, gene expression was analyzed in identical fat depots explanted from
all mice in the cohort as described above. Veterinary care was provided by
the Division of Comparative Medicine. All animals were maintained under
the guidlines of the U.T. Southwestern Medical Center Animal Care and
Use Committee according to current NIH guidelines.
Acknowledgments
We thank Drs. C. Dearolf, T. Furakawa, J. Jiang, A. McMahon, G. Nolan, B.
Spiegelman, and D. Turner for reagents. We thank Drs. W. Dauer, M. Henke-
meyer, M. Kyba, L. Parada, and R. Perlingeiro for helpful discussions. We
thank members of the Graff lab for insights, help, and reagents. This work
was supported by awards to J.M.G. from the National Institutes of Health
(NIH) and the National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK). J.M.G. is an American Cancer Society Scholar and a
Leukemia and Lymphoma Society Scholar.
Received: June 2, 2005
Revised: October 10, 2005
Accepted: November 17, 2005
Published: January 10, 2006
References
Ashrafi, K., Chang, F.Y., Watts, J.L., Fraser, A.G., Kamath, R.S., Ahringer, J.,
and Ruvkun, G. (2003). Genome-wide RNAi analysis of Caenorhabditis ele-
gans fat regulatory genes. Nature 421, 268–272.
Bak, M., Hansen, C., Tommerup, N., and Larsen, L.A. (2003). The Hedgehog
signaling pathway–implications for drug targets in cancer and neurodegener-
ative disorders. Pharmacogenomics 4, 411–429.
Brand, A.H., Manoukian, A.S., and Perrimon, N. (1994). Ectopic expression in
Drosophila. Methods Cell Biol. 44, 635–654.
Buhman, K.K.,Wang, L.C., Tang, Y., Swietlicki, E.A., Kennedy, S., Xie, Y., Liu,
Z.Y., Burkly, L.C., Levin, M.S., Rubin, D.C., and Davidson, N.O. (2004). Inhi-
bition of Hedgehog signaling protects adult mice from diet-induced weight
gain. J. Nutr. 134, 2979–2984.
Cadigan, K., and Nusse, R. (1997). Wnt signaling: a common theme in animal
development. Genes Dev. 11, 3286–3305.
Chen, J.K., Taipale, J., Cooper, M.K., and Beachy, P.A. (2002). Inhibition of
Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes
Dev. 16, 2743–2748.
Chen, P.L., Riley, D.J., Chen, Y., and Lee, W.H. (1996). Retinoblastoma pro-
tein positively regulates terminal adipocyte differentiation through direct in-
teraction with C/EBPs. Genes Dev. 10, 2794–2804.G and H) 10T1/2 multipotent mesenchymal cells were infected with a virus encoding either GFP or Gata, incubated in adipogenic induction media, and adipogenesis
was scored microscopically (G) and molecularly (H).
I) C3H10T1/2s expressing GFP or Gata were adipogenically induced and RNA was extracted. Real-time PCR showed that Gata induced the expression of the oste-
ogenic transcription factors, Runx2 and Osx. b-actin serves as a loading control for real-time PCR (H and I). *p < 0.0133
A R T I C L ECinti, S. (2000). Anatomy of the adipose organ. Eat. Weight Disord. 5, 132–
142.
Craven, S.E., Lim, K.C., Ye, W., Engel, J.D., De Sauvage, F., and Rosenthal,
A. (2004). Gata2 specifies serotonergic neurons downstream of sonic hedge-
hog. Development 131, 1165–1173.
Duman-Scheel, M., Weng, L., Xin, S., and Du,W. (2002). Hedgehog regulates
cell growth and proliferation by inducing Cyclin D and Cyclin E. Nature 417,
299–304.
Fajas, L., Egler, V., Reiter, R., Hansen, J., Kristiansen, K., Debril, M.B., Miard,
S., andAuwerx, J. (2002). The retinoblastoma-histone deacetylase 3 complex
inhibits PPARgamma and adipocyte differentiation. Dev. Cell 3, 903–910.
Gering, M., and Patient, R. (2005). Hedgehog signaling is required for adult
blood stem cell formation in zebrafish embryos. Dev. Cell 8, 389–400.
Graff, J. (1997). Embryonic patterning: To BMP or not to BMP that is the
question. Cell 89, 171–174.
Gratzner, H.G. (1982).Monoclonal antibody to 5-bromo- and 5-iododeoxyuri-
dine: A new reagent for detection of DNA replication. Science 218, 474–475.
Hansen, J.B., Jorgensen, C., Petersen, R.K., Hallenborg, P., De Matteis, R.,
Boye, H.A., Petrovic, N., Enerback, S., Nedergaard, J., Cinti, S., et al. (2004).
Retinoblastoma protein functions as a molecular switch determining white
versus brown adipocyte differentiation. Proc. Natl. Acad. Sci. USA 101,
4112–4117.
Hoshizaki, D.K., Blackburn, T., Price, C., Ghosh, M., Miles, K., Ragucci, M.,
and Sweis, R. (1994). Embryonic fat-cell lineage in Drosophila melanogaster.
Development 120, 2489–2499.
Ingham, P.W., and McMahon, A.P. (2001). Hedgehog signaling in animal de-
velopment: paradigms and principles. Genes Dev. 15, 3059–3087.
Ingram, W.J., Wicking, C.A., Grimmond, S.M., Forrest, A.R., andWainwright,
B.J. (2002). Novel genes regulated by Sonic Hedgehog in pluripotent mesen-
chymal cells. Oncogene 21, 8196–8205.
Karsenty, G. (1998). Transcriptional regulation of osteoblast differentiation
during development. Front. Biosci. 3, d834–d837.
Kenney, A.M., and Rowitch, D.H. (2000). Sonic hedgehog promotes G(1) cy-
clin expression and sustained cell cycle progression in mammalian neuronal
precursors. Mol. Cell. Biol. 20, 9055–9067.
Li, X., Blagden, C.S., Bildsoe, H., Bonnin,M.A., Duprez, D., andHughes, S.M.
(2004). Hedgehog can drive terminal differentiation of amniote slow skeletal
muscle. BMC Dev. Biol. 4, 9.
MacDougald, O.A., and Lane, M.D. (1995). Transcriptional regulation of gene
expression during adipocyte differentiation. Annu. Rev. Biochem. 64, 345–
373.
Marigo, V., Johnson, R.L., Vortkamp, A., and Tabin, C.J. (1996). Sonic hedge-
hog differentially regulates expression of GLI and GLI3 during limb develop-
ment. Dev. Biol. 180, 273–283.
Martin, P.L., Lane, J., Pouliot, L., Gains, M., Stejskal, R., Smith, S.Y., Galdes,
A., and Green, J. (2002). Increase in adipose and total body weight, but not in
lean body mass, associated with subcutaneous administration of sonic
hedgehog-Ig fusion protein to mice. Drug Dev. Res. 57, 107–114.
McKay, R.M., McKay, J.P., Avery, L., and Graff, J.M. (2003). C. elegans. A
Model for Exploring the Genetics of Fat Storage. Dev. Cell 4, 131–142.
McMahon, A.P., Ingham, P.W., and Tabin, C.J. (2003). Developmental roles
and clinical significance of hedgehog signaling. Curr. Top. Dev. Biol. 53, 1–
114.
Mikkola, H.K., and Orkin, S.H. (2002). The search for the hemangioblast.
J. Hematother. Stem Cell Res. 11, 9–17.
Molkentin, J.D., and Olson, E.N. (1996). Defining the regulatory networks for
muscle development. Curr. Opin. Genet. Dev. 6, 445–453.
Ramirez-Zacarias, J.L., Castro-Munozledo, F., and Kuri-Harcuch, W. (1992).
Quantitation of adipose conversion and triglycerides by staining intracyto-
plasmic lipids with Oil red O. Histochemistry 97, 493–497.34Rosen, E.D., and Spiegelman, B.M. (2000). Molecular regulation of adipogen-
esis. Annu. Rev. Cell Dev. Biol. 16, 145–171.
Rosenfeld, J.M., and Osborne, T.F. (1998). HLH106, a Drosophila sterol reg-
ulatory element-binding protein in a natural cholesterol auxotroph. J. Biol.
Chem. 273, 16112–16121.
Ross, S., Hemati, N., Longo, K., Bennett, C., Lucas, P., Erickson, R., and
MacDougald, O. (2000). Inhibition of adipogenesis by Wnt signaling. Science
289, 950–953.
Sasaki, H., Nishizaki, Y., Hui, C., Nakafuku, M., and Kondoh, H. (1999). Reg-
ulation of Gli2 andGli3 activities by an amino-terminal repression domain: im-
plication of Gli2 andGli3 as primarymediators of Shh signaling. Development
126, 3915–3924.
Shi, X., Shi, W., Li, Q., Song, B., Wan, M., Bai, S., and Cao, X. (2003). A glu-
cocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of
mesenchymal cells. EMBO Rep. 4, 374–380.
Smith, V.M., Lee, P.P., Szychowski, S., and Winoto, A. (1995). Gata-3 dom-
inant negative mutant. J. Biol. Chem. 270, 1515–1520.
Sottile, V., and Seuwen, K. (2000). Bone morphogenetic protein-2 stimulates
adipogenic differentiation of mesenchymal precursor cells in synergy with
BRL 49653 (rosiglitazone). FEBS Lett. 475, 201–204.
Spiegelman, B.M., and Flier, J.S. (2001). Obesity and the regulation of energy
balance. Cell 104, 531–543.
Spinella-Jaegle, S., Rawadi, G., Kawai, S., Gallea, S., Faucheu, C., Mollat, P.,
Courtois, B., Bergaud, B., Ramez, V., Blanchet, A.M., et al. (2001). Sonic
hedgehog increases the commitment of pluripotent mesenchymal cells
into the osteoblastic lineage and abolishes adipocytic differentiation.
J. Cell Sci. 114, 2085–2094.
Sul, H.S., Smas, C., Mei, B., and Zhou, L. (2000). Function of pref-1 as an in-
hibitor of adipocyte differentiation. Int. J. Obes. Relat. Metab. Disord. 24
(Suppl 4), S15–S19.
Sweet, H.O., Bronson, R.T., Donahue, L.R., and Davisson, M.T. (1996). Mes-
enchymal dysplasia: a recessive mutation on chromosome 13 of the mouse.
J. Hered. 87, 87–95.
Taipale, J., Chen, J.K., Cooper, M.K., Wang, B., Mann, R.K., Milenkovic, L.,
Scott, M.P., and Beachy, P.A. (2000). Effects of oncogenic mutations in
Smoothened and Patched can be reversed by cyclopamine. Nature 406,
1005–1009.
Tang, Q.Q., Otto, T.C., and Lane, M.D. (2003). Mitotic clonal expansion:
a synchronous process required for adipogenesis. Proc. Natl. Acad. Sci.
USA 100, 44–49.
Taylor, S.M., and Jones, P.A. (1979). Multiple phenotypes induced in 10T1/2
and 3T3 cells treated with 5-azacytidine. Cell 17, 771–779.
Tong, Q., Dalgin, G., Xu, H., Ting, C.N., Leiden, J.M., and Hotamisligil, G.S.
(2000). Function of GATA transcription factors in preadipocyte-adipocyte
transition. Science 290, 134–138.
van der Horst, G., Farih-Sips, H., Lowik, C.W., and Karperien, M. (2003).
Hedgehog stimulates only osteoblastic differentiation of undifferentiated
KS483 cells. Bone 33, 899–910.
Wang, G., Amanai, K., Wang, B., and Jiang, J. (2000). Interactions with Cos-
tal2 and suppressor of fused regulate nuclear translocation and activity of cu-
bitus interruptus. Genes Dev. 14, 2893–2905.
Wang, G., and Jiang, J. (2004). Multiple Cos2/Ci interactions regulate Ci sub-
cellular localization through microtubule dependent and independent mech-
anisms. Dev. Biol. 268, 493–505.
Wang, L.C., Nassir, F., Liu, Z.Y., Ling, L., Kuo, F., Crowell, T., Olson, D., Da-
vidson, N.O., and Burkly, L.C. (2002). Disruption of hedgehog signaling re-
veals a novel role in intestinal morphogenesis and intestinal-specific lipidme-
tabolism in mice. Gastroenterology 122, 469–482.
Wu, X., Walker, J., Zhang, J., Ding, S., and Schultz, P.G. (2004). Purmorph-
amine induces osteogenesis by activation of the hedgehog signaling path-
way. Chem. Biol. 11, 1229–1238.CELL METABOLISM : JANUARY 2006
